Impact of combined alpha-lipoic acid and mitoquinone supplementation on myocardial infarction in aged rats: Heart performance and molecular mechanisms

Exp Gerontol. 2024 May:189:112402. doi: 10.1016/j.exger.2024.112402. Epub 2024 Mar 19.

Abstract

Background: This study aimed to investigate the effects of combined alpha-lipoic acid (ALA) and mitoquinone (Mito Q) supplementation on cardiac function and the underlying mechanisms in aged rats with myocardial infarction (MI).

Methods: The aged rats underwent left anterior descending artery (LADA) occlusion for 30 min, followed by reperfusion for 24 h. ALA (100 mg/kg, gavage) and Mito Q (10 mg/kg, IP) were administered daily for two weeks before ischemia. Cardiac function, inflammatory, and apoptotic markers were evaluated 24 h after ischemia.

Results: The results of this study indicated that the administration of the combination of ALA and Mito Q significantly improved cardiac function. This improvement was linked to a reduction in the expression of pro-inflammatory cytokines TNF-α, IL-6, and IL-1β (P < 0.001) and apoptotic markers (Bax, caspase-3, and Cyt-c), as well as a decrease in the percentage of TUNEL-positive cells (P < 0.001).

Conclusion: The study revealed that combined intervention synergistically mitigated cardiac dysfunction by suppressing inflammatory and apoptotic pathways in aged rats with MI. Further research is needed to validate the potential of ALA and Mito Q as therapeutic options for elderly people at risk of heart attacks.

Keywords: Aged rats; Alpha-lipoic acid; Apoptosis; Combination; Inflammation; Mito Q; Myocardial infarction.

MeSH terms

  • Aged
  • Animals
  • Apoptosis
  • Dietary Supplements
  • Humans
  • Myocardial Infarction* / drug therapy
  • Organophosphorus Compounds*
  • Rats
  • Rats, Sprague-Dawley
  • Thioctic Acid* / pharmacology
  • Thioctic Acid* / therapeutic use
  • Ubiquinone / analogs & derivatives*

Substances

  • Thioctic Acid
  • mitoquinone
  • Organophosphorus Compounds
  • Ubiquinone